Our successes
Life Sciences
- Microbiome / Nutrition / Foodtech / Lifestyle
- Medtech / Connected health / Digital health
- Biotech & pharmaceuticals
- Industrial Biotech & Cleantech
- Animal health / Animal Feed & Nutrition
Digital Technologies
- Fintech
- Retailtech
- Other digital innovative solutions
- Hardware & telecom
News
-
30 June 2023Enterome announces first patient dosed in a Phase 1/2 trial with third OncoMimics™ immunotherapy, EO4010, in Metastatic Colorectal Cancer
Read more...Enterome today announces that the first patient was...
-
14 June 2023
Enterome’s new OncoMimics™ immunotherapy, EO2463, demonstrates early efficacy and favorable safety in Phase 1/2 trial for indolent non-Hodgkin lymphoma
Read more...Enterome, a clinical-stage company developing...
-
31 May 2023
Enterome announces sustained positive clinical outcomes with EO2401
Read more...Enterome, a clinical-stage company developing...
-
23 May 2023
Galecto Completes Dosing in 52-Week Phase 2b GALACTIC-1 Trial of GB0139 in Idiopathic Pulmonary Fibrosis
Read more...Galecto, Inc., a clinical-stage biotechnology company...
-
9 May 2023Vedanta Biosciences Receives Fast Track Designation for VE303 and Presents Phase 2 Data at Digestive Disease Week
Read more...Exploratory analyses from the VE303 Phase 2 CONSORTIUM...
Events
-
30 January
HUBDAY Future of Retail & E-Commerce
Come & meet us !
-
31 January
Maddy Keynote
Come & meet us !
-
04 February
France Digital Tour – Bordeaux
Come & meet us !
-
05 February
FRANKFURT DIGITAL FINANCE
Come & meet us !
-
28 February
Paris Fintech Forum
Come & meet us !